Regeneron Ventures

Regeneron Ventures operates as a specialized healthcare venture capital fund, strategically investing in companies poised to enhance health outcomes. The firm focuses on breakthrough innovation across biotechnology, medical devices, research tools, and enabling technologies, making investment decisions based on the quality of personnel, scientific rigor, and robust data. It aims to support the development of novel solutions that address significant patient needs.

Launched in April 2024, Regeneron Ventures was established with Regeneron Pharmaceuticals, Inc. as its sole limited partner. While functioning independently, the venture fund adheres to the patient-centric and science-driven mission, principles, and values synonymous with its parent organization. This foundation provides a deep scientific and operational context for its investment thesis.

The fund serves early-stage and growth-stage companies within the healthcare ecosystem, providing capital and strategic guidance. Its overarching vision is to assist its portfolio companies in translating promising ideas into impactful products that genuinely benefit patients, thereby driving long-term success through improved health.